GW Pharmaceuticals CEO: How we separate ourselves from medical marijuana companies

6:48 PM ET Wed, 27 Feb 2019

This stock shot up more than 13 percent during Wednesday's session. Jim Cramer talks with CEO Justin Glover about how their operation differs from the competition.